Numerical simulation of hot-melt extrusion processes for amorphous solid dispersions using model-based melt viscosity

• Published in: European journal of pharmaceutics and biopharmaceutics Vol. 124; pp. 34 - 42
• Main Authors: Bochmann, Esther S., Steffens, Kristina E., Gryczke, Andreas, Wagner, Karl G.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.03.2018
• Subjects: Amorphous solid dispersion; Glass transition temperature; Hot-melt extrusion; Melt rheology; Prediction model; Simulation; Hot-melt extrusion; Amorphous solid dispersion; Ibuprofen (PubChem CID: 3672); Melt rheology; Copovidone (PubChem CID: 25086-89-9); Simulation; Prediction model; Carbamazepine (PubChem CID: 2554); Dipyridamole (PubChem CID: 3108); Glass transition temperature; Indomethacin (PubChem CID: 3715); melt rheology; prediction model; simulation; hot-melt extrusion; glass transition temperature; amorphous solid dispersion
• ISSN: 0939-6411; 1873-3441
• DOI: 10.1016/j.ejpb.2017.12.001

[Display omitted] Simulation of HME processes is a valuable tool for increased process understanding and ease of scale-up. However, the experimental determination of all required input parameters is tedious, namely the melt rheology of the amorphous solid dispersion (ASD) in question. Hence, a procedure to simplify the application of hot-melt extrusion (HME) simulation for forming amorphous solid dispersions (ASD) is presented. The commercial 1D simulation software Ludovic® was used to conduct (i) simulations using a full experimental data set of all input variables including melt rheology and (ii) simulations using model-based melt viscosity data based on the ASDs glass transition and the physical properties of polymeric matrix only. Both types of HME computation were further compared to experimental HME results. Variation in physical properties (e.g. heat capacity, density) and several process characteristics of HME (residence time distribution, energy consumption) among the simulations and experiments were evaluated. The model-based melt viscosity was calculated by using the glass transition temperature (Tg) of the investigated blend and the melt viscosity of the polymeric matrix by means of a Tg-viscosity correlation. The results of measured melt viscosity and model-based melt viscosity were similar with only few exceptions, leading to similar HME simulation outcomes. At the end, the experimental effort prior to HME simulation could be minimized and the procedure enables a good starting point for rational development of ASDs by means of HME. As model excipients, Vinylpyrrolidone-vinyl acetate copolymer (COP) in combination with various APIs (carbamazepine, dipyridamole, indomethacin, and ibuprofen) or polyethylene glycol (PEG 1500) as plasticizer were used to form the ASDs.